Synthesis and anti-HIV activity of β-D-3′-azido-2′, 3′-unsaturated nucleosides and β-D-3′-azido-3′- deoxyribofuranosylnucleosides

Nucleosides, Nucleotides and Nucleic Acids

Volumn 24, Issue 10-12, 2005, Pages 1707-1727

  Gadthula, Srinivas ^a   Chu, Chung K ^a   Schinazi, Raymond F ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

D 3 azido 2 ,3 unsaturated nucleosides; D 3 azido 3 deoxyribofuranosylnucleosides; Anti HIV activity; Nucleosides

Indexed keywords

2',3' DIDEHYDRO 2',3' DIDEHYDRO 2',3' DIDEOXYTHYMIDINE; 3 AZIDO 2',3' DIDEHYDRO 2',3' DIDEOXY BETA DEXTRO RIBOFURANOSYLADENINE; 3' AZIDO 2' O TRIFLYL 5' O BENZOYL 3' DEOXY BETA DEXTRO RIBOFURANOSYL N 2 ACETYLGUANINE; 3' AZIDO 2',3' DIDEHYDRO 2',3' DIDEOXY BETA DEXTRO RIBOFURANOSYLCYTOSINE; 3' AZIDO 2',3' DIDEHYDRO 2',3' DIDEOXY BETA DEXTRO RIBOFURANOSYLTHYMINE; 3' AZIDO 3' DEOXY BETA DEXTRO RIBOFURANOSYLADENINE; 3' AZIDO 3' DEOXY BETA DEXTRO RIBOFURANOSYLCYTOSINE; 3' AZIDO 3' DEOXY BETA DEXTRO RIBOFURANOSYLGUANINE; 3' AZIDO 3' DEOXY BETA DEXTRO RIBOFURANOSYLTHYMINE; ADENINE; ANTIVIRUS AGENT; CYTOSINE; GUANINE; PURINE NUCLEOSIDE DERIVATIVE; PYRIMIDINE; THYMINE; UNCLASSIFIED DRUG; XYLOSE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL REACTION; DRUG SYNTHESIS; ELECTRON; HUMAN IMMUNODEFICIENCY VIRUS; STRUCTURE ANALYSIS; VIRUS REPLICATION;

ANTI-HIV AGENTS; CELLS, CULTURED; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE; VIRUS REPLICATION; XYLOSE; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 29244465548     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770500267170     Document Type: Article

References (24)

1. Mitsuya, H.; Weinhold, K.J.; Furman, P.A.; St. Clair, M.H.; Nusinoff Lehrman, S.; Gallo, R.C.; Bolognesi, D.; Barry, D.W.; Border, S. 3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 7096-7100.
2. (a) Hamamoto, Y.; Yamamoto, N.; Matsui, T.; Matsuda, A.; Ueda, T.; Yamamoto, N. Inhibitory effect of 2′,3′-didehydro-2′,3′- dideoxynucleosides on infectivity, cytopathetic effects and replication of human immunodeficiency virus. Antimicrob. Agents Chemother. 1987, 31, 907-910.
3. (b) Lin, T.S.; Schinazi, R.F.; Prusoff, W.H. Potent and selective in vitro activity of 3′-deoxyadenosine, deoxythymidine-2′-ene (3′-deoxy-2′,3′-didehydrothymidine) against human immunodeficiency virus in vitro. Biochem. Pharmacol. 1987, 36, 2713-2718.
4. Zidovudine (AZT), Didanosine (ddI), Zalcitabine (ddC), Stavudine (d4T), Lamivudine (3TC), Abacavir (ABC).
5. Chun, B.K.; Schinazi, R.F.; Cheng, Y.C.; Chu, C.K. Synthesis of 2′,3′-dideoxy-3′-fluoro-L-ribonucleosides as potential antiviral agents from D-sorbitol. Carbohydrate Res. 2000, 328, 49-59.
6. Lee, K.; Choi, Y.; Gullen, E.; Schlueter-Wirtz, S.; Schinazi, R.F.; Cheng, Y.C.; Chu, C.K. Synthesis and anti-HIV and anti-HBV activities of 2′-fluoro-2′,3′-unsaturated L-nucleosides. J. Med. Chem. 1999, 42, 1320-1328.
7. Lee, K.; Choi, Y.S.; Gumina, G.; Zhou, W.; Schinazi, R.F.; Chu, C.K. Structure-activity relationships of 2′-fluoro-2′,3′- unsaturated D-nucleosides as anti-HIV-1 agents. J. Med. Chem. 2002, 45, 1313-1320.
8. Chong, Y.H.; Gumina, G.; Mathew, J.; Schinazi, R.F.; Chu, C.K. L-2′,3′-Didehydro-2′,3′-dideoxy-3′- fluoronucleosides: Synthesis, anti-HIV activity, chemical and enzymatic stability and the mechanism of resistance. J. Med. Chem. 2003, 46, 3245-3256.
9. Zhou, W.; Gumina, G.; Chong, Y.H.; Wang, J.; Schinazi, R.F.; Chu, C.K. Synthesis, structure-activity relationships and drug resistance of β-D-3′-fluoro-2′,3′-unsaturated nucleosides as anti-HIV agents. J. Med. Chem. 2004, 47, 3399-3408.
10. Chong, Y.H.; Choo, H.A.; Choi, Y.S.; Schinazi, R.F.; Chu, C.K. Stereoselective synthesis and antiviral activity of D-2′,3′- didehydro-2′,3′dideoxy-2′-fluoro-4′-thionucleosides. J. Med. Chem. 2002, 45, 4888-4898.
11. Choo, H.A.; Chong, Y.H.; Choi, Y.S.; Mathew, J.; Schinazi, R.F; Chu, C.K. Synthesis, anti-HIV activity and molecular mechanism of drug resistance of L-2′,3′-didehydro-2,3′-dideoxy-2′-fluoro-4′- thionucleosides. J. Med. Chem. 2003, 46, 389-398.
12. Zhu, W.; Chong, Y.H.; Choo, H.; Chong, Y.H.; Mathews, J.; Schinazi, R.F.; Chu, C.K. Synthesis, structure-activity relationships and mechanism of drug resistance of D- and L-β-3′-fluoro-2′,3′-unsaturated- 4′-thionucleosides as anti-HIV agents. J. Med. Chem. 2004, 47, 1631-1640.
13. Zhu, W.; Gumina, G.; Schinazi, R.F.; Chu, C.K. Synthesis and anti-HIV activity of L-β-3′-C-cyano-2′,3′-unsaturated nucleosides and L-3′-C-cyano-3′-deoxyribonucleosides. Tetrahedron 2003, 59, 6423-6431.
14. Moses Nam Fong, L. Preparation of pyrimidirie nucleoside analogs as antivirals. Eur. Pat. Appl., 1989, EP 348170 A2 19891227.
15. Bozo, E.; Boros, S.; Kuszmann, J.; Gacs-Baitz, E.; Parkanyi, L. An economic synthesis of 1,2,3,4-tetra-O-acetyl-5-thio-D-xylopyranose and its transformation into 4-substituted-phenyl 1,5-dithio-D-xylopyranosides possessing antithrombotic activity. Carbohydr. Res. 1998, 308, 297-310.
16. Gruner, S.A.W.; Truffault, V.; Voll, G.; Locardi, E.; Stockle, M.; Kessler, H. Design, synthesis and NMR structure of linear and cyclic oligomers containing novel furanoid sugar amino acids. Chem. Eur. J. 2002, 8(19), 4365-4376.
17. Ozols, A.M.; Azhayev, A.V.; Dyatkina, N.B.; Krayevsky, A.A. Aminonucleosides and their derivatives; VI. A new synthesis of 1,2,5-tri-O-acyl-3-azido-3-deoxy-β-D-ribofuranose. Synthesis 1980, 557-559.
18. Hasegawa, A.; Goto, M.; Kiso, M. An unusual behavior of methyl or benzyl 3-azido-5-O-benzoyl-3,6-dideoxy-α-L-talofuranoside with (dimethylamino) sulfur trifluoride. Migration of the alkoxyl group from the C-1 to the C-2 position. J. Carbohydr. Chem. 1985, 4(4), 627-638.
19. Song, G.Y.; Paul, V.; Choo, H.; Morrey, J.; Sidwell, R.W.; Schinazi, R.F.; Chu, C.K. Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus. J. Med. Chem. 2001, 44, 3985-3993.
20. Elliott, R.P.; Fleet, G.W.J.; Vogt, K.; Wilson, F.X.; Wang, Y.; Witty, D.R.; Storer, R.; Mayers, P.L.; Wallis, C.J. Attempted ring contraction of α-triflates of 3′-azido and 3′-fluoro-7-lactones to oxetanes. Tetrahedron: Asymmetry 1990, 1(10), 711-714.
21. Gryaznov, S.M.; Winter, H. RNA mimetics: Oligoribonucleotide N3′→P5′ phosphoramidates. Nucleic Acids Res. 1998, 26, 4160-4167.
22. Rompaey, P.V.; Nauwelaerts, K.; Vanheusden, V.; Rozenski, J.; Munier-Lehmann, H.; Herdewijn, P.; Calenbergh, S.V. Mycobacterium tuberculosis thymidine monophosphate kinase inhibitors: Biological evaluation and conformational analysis of 2′- and 3′-modified thymidine analogues. Eur. J. Org. Chem. 2003, 2911-2918.
23. Botta, O.; Moyroud, E.; Lobato, C.; Strazewski, P. Synthesis of 3′-azido- and 3′-deoxyadenosine in both enantiomeric forms. Tetrahedron 1998, 54, 13529-13546.
24. Zou, R.; Robins, M.J. High-yield regioselective synthesis of 9-glycosyl guanine nucleosides and analogues via coupling with 2-N-acetyl-6-O- diphenylcarbamoylguanine. Can. J. Chem. 1987, 65, 1436-1437.